Target Healthcare REIT (LSE:THRL) Beta: -0.1299 (As of Jun. 24, 2026)


LSE:THRL Target Healthcare REIT PLC LSE:THRL
32 GF Score
Price £1.04
GF Value £0.89
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Target Healthcare REIT Beta?

Target Healthcare REIT LSE:THRL -1.14% 32 Beta is -0.1299 as of Jun. 24, 2026. GuruFocus rates LSE:THRL with a GF Score™ of 32/100 and a GF Value™ of £0.89 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Target Healthcare REIT's Beta is -0.1299.


Target Healthcare REIT  (LSE:THRL) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Target Healthcare REIT Beta Related Terms


Target Healthcare REIT Beta Historical Data

* Premium members only.

The historical data trend for Target Healthcare REIT's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Target Healthcare REIT Beta Chart

Target Healthcare REIT Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.80 0.54

Target Healthcare REIT Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.69 -0.80 0.77 0.54 0.29

LSE:THRL vs WELL, VTR, OHI: Beta Comparison

For the REIT - Healthcare Facilities subindustry, Target Healthcare REIT's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Target Healthcare REIT Beta vs REITs Industry

For the REITs industry and Real Estate sector, Target Healthcare REIT's Beta distribution charts can be found below:

* The bar in red indicates where Target Healthcare REIT's Beta falls into.


LSE:THRL
32GF Score
Target Healthcare REIT PLC LSE:THRL
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Target Healthcare REIT Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.1299 mean?
Target Healthcare REIT (LSE:THRL) has a Beta of -0.1299 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Target Healthcare REIT and its competitors.
Is Target Healthcare REIT's Beta too high?
Target Healthcare REIT's current Beta is -0.1299. Overall, Target Healthcare REIT has a GF Score™ of 32/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Target Healthcare REIT's Beta compare to WELL and VTR?
Target Healthcare REIT's Beta of -0.1299 can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a REITs company?
A good Beta depends on the REITs industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Target Healthcare REIT and its competitors. Target Healthcare REIT's current Beta is -0.1299. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Target Healthcare REIT stock overvalued right now?
Based on GuruFocus' analysis, Target Healthcare REIT (LSE:THRL) is currently considered Modestly Overvalued. The stock's GF Value™ is £0.89, compared to a current price of £1.04 — trading 16.9% above its estimated fair value. The current Beta is -0.1299. Target Healthcare REIT's overall GF Score™ is 32/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Target Healthcare REIT (LSE:THRL), the current Beta is -0.1299 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Target Healthcare REIT (LSE:THRL) Overvalued in 2026?

Based on GuruFocus' analysis, Target Healthcare REIT stock appears to be overvalued. The current stock price of £1.04 is trading 16.9% above its estimated GF Value™ of £0.89. GuruFocus considers Target Healthcare REIT to be Modestly Overvalued.

Key valuation signals for LSE:THRL:

  • Beta: -0.1299
  • GF Value™: £0.89 vs. price of £1.04 (16.9% above fair value)
  • GF Score™: 32/100 with 7 warning signs

No single metric tells the full story. See the LSE:THRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Target Healthcare REIT Business Description

Industry Real EstateREITs
Address 69 Old Broad Street, Level 4, Dashwood House, London, GBR, EC2M 1QS
Target Healthcare REIT PLC is an investment company that acts as a long-term investor in care homes in the United Kingdom. The investment objective of the company is to provide shareholders with an attractive level of income together with the potential for capital and income growth from investing in a diversified portfolio of freehold and long-leasehold care homes, which are let to care home operators, and other healthcare assets in the United Kingdom.
32GF Score

Get the complete analysis for LSE:THRL

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£1.04
Price
£0.89
GF Value